Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GeneDx Holdings Corp.

Get SEC filing alerts via email and in your feed for GeneDx Holdings Corp.

WGS WGSWW

GeneDx Holdings Corp.

About GeneDx Holdings Corp.

GeneDx Holdings specializes in genetic testing and genomic interpretation for rare and complex diseases. Utilizing exome and whole genome sequencing, the company provides diagnostic solutions, data analysis, and interpretation services to healthcare providers, researchers, and biopharma partners. Its industry-leading dataset and advanced bioinformatics enable accurate, scalable, and actionable genetic insights, primarily serving pediatric and rare disease markets worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from GeneDx Holdings Corp.

1
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 17% Revenue Growth but Faces Increased Net Loss in Latest Quarter

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 40% Revenue Growth to $427.5 Million in 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 52% Revenue Growth to $116.7 Million in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 46% Revenue Growth and Net Income Turnaround in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 40% Revenue Growth to $87.1 Million in Latest Quarter

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 51% Revenue Growth to $305.5 Million in 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
GeneDx Holdings Corp. GeneDx Holdings Corp. Reports 44% Revenue Growth, Improved Operational Performance in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments